Effect of dexmetetomiding during the perioperative period on the postoperative pain of patients after open resection of liver cancer

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17011001

Enrollment

Unknown

Registered

2017-03-28

Start date

2017-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

oxycodone :oxycodone

oxycodone + dexmedetomidine:dexmedetomidine

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Aged 18-70years; ASA I-II; Dignosed liver cancer with CT; Child-Pugh A;

Exclusion criteria

Exclusion criteria: Severe liver or renal insufficency; cardiovascular disease; allergy to any of the drugs like midazolam, opiods and dexmedetomidine; sedative and analgesic drugs abuse; with a history of asthma; comminication difficulties.

Design outcomes

Primary

Measure	Time frame
Postoperative pain scores;Postoperative oxycodone consumption;	—

Secondary

Measure	Time frame
LOS;Postoperative renal function;perioperative remifentanil consumption;perioperative propofol consumption;	—

Countries

China

Contacts

Public ContactBenhou Zhang

Beijing Youan Hospital, Capital Medical University

benhou2008@163.com+86 13601293049

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026